PIRS
Pieris Pharmaceuticals, Inc.
No insider bought or sold Pieris Pharmaceuticals, Inc. in the last 12 months
$0Bought, 12 mo
$0Sold, 12 mo
PIRS over the last year
PIRS after insider buys
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
12 insider filings since 2017, newest first
PIRSBuy
Adar1 Capital Management, LLC · 10% owner
$92K+4.0%Aug 12
PIRSSell
Shane Olwill · Chief Development Officer
$196K−89.0%Sep 1
PIRSSell
Aquilo Capital Management, LLC · 10% owner
$5.6M−34.0%Jul 22
PIRSSell
Bvf Partners L P/il · 10% owner
$225K−14.0%Sep 10
PIRSBuy
Christopher P Kiritsy · Director
$26K+100.0%Sep 17
PIRSBuy
James A Geraghty · Director
$58K+100.0%May 16
PIRSSell
Orbimed Advisors LLC · 10% owner
$6.3M−96.0%May 2
PIRSSell
Orbimed Advisors LLC · 10% owner
$71K−14.0%Feb 15
PIRSSell
Orbimed Advisors LLC · 10% owner
$12.6M−97.0%Jan 4
PIRSSell
Orbimed Advisors LLC · 10% owner
$842K−69.0%Dec 20
PIRSBuy
James A Geraghty · Director
$48KAug 17
PIRSBuy
Allan Reine · Insider
$313KAug 17
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.